Effect of service screening mammography on population mortality from breast carcinoma

Cancer

Volumn 95, Issue 3, 2002, Pages 451-457

  Feig, Stephen A ^a  

^a MOUNT SINAI HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; FOLLOW UP; HUMAN; MAMMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; SURVIVAL ANALYSIS; SURVIVAL RATE; SWEDEN; TIME FACTORS;

EID: 0036682064     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10764     Document Type: Review

References (39)

1. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up
2. Is screening for breast cancer with mammography justifiable?
3. Cochrane review on screening for breast cancer with mammography
4. Mammography screening does not reduce breast cancer mortality
5. 14 Years of follow-up from Edinburgh randomized trial of breast cancer screening
6. Breast cancer screening with mammography: Overview of Swedish randomized trials
7. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years
8. Canadian National Breast Screening Study 2: 13-Year results of a randomized trial in women aged 50-59 years
9. The Canadian National Breast Screening Study: A critical review
10. Dedicated mammographic X-ray equipment, screen-film processing systems and viewing conditions for mammography
11. Screening mammography: Effect of image quality on clinical outcome
12. New Swedish breast cancer detection results for women aged 40-49
13. Mammographic film density and detection of small breast cancers
14. Estimation of currently attainable benefit from mammographic screening of women aged 40-49 years
15. Screening mammography: Clinical image quality and the risk of interval breast cancer
16. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan Trial
17. Mammographic screening: No reliable supporting evidence?
18. Mammography screening
19. Ductal carcinoma in situ: Implications for screening mammography
20. Falun meeting on breast cancer screening with mammography in women aged 40-49 years: Report of the organizing committee and collaborators
21. Increased benefit from shorter screening mammography intervals for women ages 40-49 years
22. Breast cancer computer simulation method for estimation of optimal intervals for screening
23. Evaluation of the effect on breast cancer mortality of population based mammography screening programmes
24. Increasing incidence of and declining mortality from breast carcinoma: Trends in Malmo, Sweden, 1961-1992
25. Breast carcinoma mortality rates and screening
26. Excess mortality from breast cancer in relation to mammography screening in northern Sweden
27. The excess mortality rate. A useful concept in cancer epidemiology
28. Effectiveness of the public health policy for breast cancer screening in Finland: Population based cohort study
29. Service screening with mammography of women aged 50-69 years in Sweden: Effects on mortality from breast cancer
30. Beyond randomized controlled trials: Organized mammographic screening substantially reduces breast carcinoma mortality
31. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties: A collaborative evaluation
32. No need to reconsider breast screening programme on basis of results from defective study
33. Screening mammography re-evaluated
34. Reduction in breast cancer mortality due to the introduction of mass screening in the Netherlands: Comparison with the United Kingdom
35. Progress in cancer screening over a decade: Results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys
36. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on the U.S. cancer burden
37. Tamoxifen for early breast cancer: An overview of randomized trials